Vaxfab Enterprises rights issue history
BSE: 542803Commercial Services & SuppliesSmall Cap
Vaxfab Enterprises Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2019
Last close ₹63.02down ₹0.90 (1.41%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹63.92.
28 Oct: open ₹64.00, high ₹64.00, low ₹61.10
52-week range of traded prices to 28 Oct 2026
₹32.50Low, 31 Oct 2025₹72.00High, 25 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹163 Cr3,603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 1.02
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 177
Vaxfab Enterprises has made no bonus issue or split since Oct 2019; its other changes to its shares on record are below.
Rights issues
Every one on record, latest first.
- Rights issue · 18 Jan 2023Shareholders were offered new shares. Open 18 Jan 2023 to 10 Feb 2023.